NCT01423695 - Weekly Paclitaxel and Trastuzumab in Metastatic Breast Cancer | Biotech Hunter

Enrollment

121

Participants

Timeline

Start Date

February 28, 2001

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions

Metastatic Breast Cancer

Interventions

DRUG

paclitaxel plus trastuzumab

Weekly paclitaxel (90 mg/m² iv, 12 courses) plus weekly trastuzumab (4mg/kg body weight iv as loading dose, 2 mg/kg iv from week 2 onwards; continued until disease progression)

Trial Locations (1)

D-08371

Dr. Matthias John, Glauchau